Net after-tax unrealized gain (loss)

  


|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Assets |  | Property, plant andequipment additions(a) |  | Depreciation and amortization |
|  | At December 31 |  | For the years ended December 31 |  | For the years ended December 31 |
|  | 2021 | 2020 | 2019 |  | 2021 | 2020 | 2019 |  | 2021 | 2020 | 2019 |
| Aviation | $ | 38,298  |  | $ | 38,634  |  | $ | 41,083  |  |  | $ | 445  |  | $ | 737  |  | $ | 1,031  |  |  | $ | 1,074  |  | $ | 1,142  |  | $ | 1,150  |  |
| Healthcare | 24,770  |  | 22,229  |  | 30,503  |  |  | 278  |  | 256  |  | 395  |  |  | 641  |  | 628  |  | 702  |  |
| Renewable Energy | 14,804  |  | 15,927  |  | 15,935  |  |  | 349  |  | 302  |  | 455  |  |  | 432  |  | 413  |  | 425  |  |
| Power | 23,569  |  | 24,453  |  | 26,731  |  |  | 189  |  | 245  |  | 277  |  |  | 692  |  | 749  |  | 880  |  |
| Corporate(b) | 94,256  |  | 114,220  |  | 110,309  |  |  | 25  |  | 40  |  | 58  |  |  | 168  |  | 531  |  | 384  |  |
| Total continuing | $ | 195,697  |  | $ | 215,463  |  | $ | 224,562  |  |  | $ | 1,286  |  | $ | 1,579  |  | $ | 2,216  |  |  | $ | 3,009  |  | $ | 3,464  |  | $ | 3,541  |  |

(a)Additions to property, plant and equipment include amounts relating to principal businesses purchased.(b)Included deferred income taxes that are presented as assets for purposes of our Statement of Financial Position presentation.  
We classify certain assets that cannot meaningfully be associated with specific geographic areas as “Other Global” for this purpose.

|  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |  |  |  |
| December 31  | 2021 | 2020 |
| U.S. | $ | 130,956  |  | $ | 139,768  |  |
| Non-U.S. |  |  |
| Europe | 42,213  |  | 50,121  |  |
| Asia | 11,534  |  | 12,974  |  |
| Americas | 6,406  |  | 7,084  |  |
| Other Global | 4,588  |  | 5,516  |  |
| Total Non-U.S. | $ | 64,741  |  | $ | 75,695  |  |
| Total assets (Continuing operations) | $ | 195,697  |  | $ | 215,463  |  |

  
The decrease in continuing assets in 2021 was primarily driven by lower volume and the impact of COVID-19, higher net repayment of borrowings, and funding of the GE Pension Plan. Property, plant and equipment – net associated with operations based in the United States were $8,411 million and $9,077 million at December 31, 2021 and 2020, respectively. Property, plant and equipment – net associated with operations based outside the United States were $7,198 million and $7,622 million at December 31, 2021 and 2020, respectively.  
NOTE 24. SUMMARIZED FINANCIAL INFORMATION. We account for our remaining interest in Baker Hughes (comprising 166.6 million shares with approximately 16% ownership interest as of December 31, 2021) at fair value. As of November 3, 2021, our investment in BKR ownership reduced below 20%, and as a result, we no longer have significant influence in BKR. The fair value of our interest in Baker Hughes at December 31, 2021 and 2020 was $4,010 million and $7,319 million, respectively. We recognized a realized and unrealized pre-tax gain of $938 million ($696 million after-tax) based on a share price of $24.06, a realized and unrealized pre-tax loss of $2,037 million ($1,562 million after-tax) based on a share price of $20.85 and a pre-tax unrealized gain of $793 million ($626 million after-tax) based on a share price of $25.63 for the years ended December 31, 2021, 2020 and 2019, respectively. The 2021 gain and 2020 loss included a $129 million pre-tax derivative gain and a $54 million pre-tax derivative loss, respectively, associated with the forward sale of Baker Hughes shares pursuant to our previously announced program to monetize our Baker Hughes position. During the years ended December 31, 2021 and 2020, we completed forward sales of 183 million and 28 million shares and received proceeds of $4,145 million and $417 million, respectively. In February 2022, we completed a forward sale of 50 million shares and received proceeds of $1,302 million. See Notes 2 and 3 for further information. Summarized financial information of Baker Hughes is as follows.  


|  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |  |  |  |  |  |  |
| For the years ended December 31 | 2021(a) | 2020 | 2019(b) |
| Revenues | $ | 16,997  |  | $ | 20,705  |  | $ | 7,751  |  |
| Gross Profit | 3,276  |  | 3,199  |  | 1,558  |  |
| Net income (loss) | (546) |  | (15,761) |  | 120  |  |
| Net income (loss) attributable to the entity | (407) |  | (9,940) |  | 60  |  |

(a) Financial information is from January 1, 2021 to November 3, 2021 (date investment in BKR reduced below 20%).(b) Financial information is from September 16, 2019 (date of deconsolidation) to December 31, 2019.  


|  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |  |  |  |
| As of December 31 | 2021(a) | 2020 |
| Current | $ | —  |  | $ | 16,455  |  |
| Noncurrent | —  |  | 21,552  |  |
| Total assets | $ | —  |  | $ | 38,007  |  |
|  |  |  |
| Current | $ | —  |  | $ | 10,227  |  |
| Noncurrent | —  |  | 9,538  |  |
| Total liabilities | $ | —  |  | $ | 19,765  |  |
| Noncontrolling interests | $ | —  |  | $ | 5,349  |  |

(a) As of November 3, 2021 (date investment in BKR reduced below 20%). As a result, we no longer have significant influence in BKR.2021 FORM 10-K 85
